Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia PatientsHarry Dolstra, Nicolaas Schaap, Aniek O. de Graaf et al.|Clinical Cancer Research|2017Cited by 211
Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemiaPaul K.J.D. de Jonge, Harry Dolstra, P.M.M. van Hauten et al.|Cancer Immunology Immunotherapy|2023Cited by 18
A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia PatientsHarry Dolstra, Nicolaas Schaap, Mieke W.H. Roeven et al.|Blood|2015Cited by 7
Functionally active NKG2A-expressing natural killer cells are elevated in rheumatoid arthritis patients compared to psoriatic arthritis patients and healthy donors.Sandra TA van Bijnen, Timothy R. D. J. Radstake, Marta Cossu et al.|PubMed|2016Cited by 3
Successful transfer of umbilical cord blood CD34 + hematopoietic stem and progenitor-derived NK cells in older acute myeloid leukemia patientsJan Spanholtz, Nicolaas Schaap, Harry Dolstra et al.|Cytotherapy|2017Cited by 1